Finance

Lists
Why is 1541 up २.५८%?
Dive Deeper
1541:HKG
ImmuneOnco Biopharmaceuticals(Shngh) Inc
HK$ २.९८
+२.५८%
(+०.०७५) 1D
अक्टोबर १६, १६:०८:१४ GMT+८  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1541...
Open
HK$ २.९८
High
HK$ ३.०७
Low
HK$ २.९२
Mkt. cap
१.२८ अरब
Avg. vol.
३.८५ लाख
Volume
२.७३ लाख
52-wk high
HK$ ११.९०
52-wk low
HK$ २.८०
EPS
-HK$ ०.६३
No. of employees
१९७
Open
HK$ २.९८
High
HK$ ३.०७
Low
HK$ २.९२
Mkt. cap
१.२८ अरब
Avg. vol.
३.८५ लाख
Volume
२.७३ लाख
52-wk high
HK$ ११.९०
52-wk low
HK$ २.८०
EPS
-HK$ ०.६३
No. of employees
१९७
News stories
From web sources and news partners
About ImmuneOnco Biopharmaceuticals(Shngh) Inc
CEO-
Employees१९७
Founded२०१५
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
५.५१ करोड
५.५१ करोड
१.८६ करोड
१.८६ करोड
Cost of goods sold
५.५५ लाख
५.५५ लाख
-
-
Cost of revenue
५.५५ लाख
५.५५ लाख
-
-
Research and development expenses
७.७१ करोड
७.७१ करोड
७.७४ करोड
७.७४ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.३३ करोड
१.३३ करोड
१.१६ करोड
१.१६ करोड
Operating expense
९.०५ करोड
९.०५ करोड
८.९० करोड
८.९० करोड
Total operating expenses
९.१० करोड
९.१० करोड
८.९० करोड
८.९० करोड
Operating income
-३.५९ करोड
-३.५९ करोड
-७.०४ करोड
-७.०४ करोड
Other non operating income
४९.०४ लाख
४९.०४ लाख
-६.५० हजार
-६.५० हजार
EBT including unusual items
-३.३३ करोड
-३.३३ करोड
-८.२७ करोड
-८.२७ करोड
EBT excluding unusual items
-३.३५ करोड
-३.३५ करोड
-७.७७ करोड
-७.७७ करोड
Income tax expense
१४.५० हजार
१४.५० हजार
११.५० हजार
११.५० हजार
Effective tax rate
-०.०४%
-०.०४%
-०.०१%
-०.०१%
Other operating expenses
-
-
-
-
Net income
-३.३० करोड
-३.३० करोड
-८.२१ करोड
-८.२१ करोड
Net profit margin
-५९.८४%
-५९.८४%
-४४०.८१%
-४४०.८१%
Earnings per share
-
-
-
-
Interest and investment income
१५.६६ लाख
१५.६६ लाख
२२.८२ लाख
२२.८२ लाख
Interest expense
-१४.३० लाख
-१४.३० लाख
-२१.१६ लाख
-२१.१६ लाख
Net interest expenses
१.३६ लाख
१.३६ लाख
१.६६ लाख
१.६६ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-३.३८ करोड
-३.३८ करोड
-६.८४ करोड
-६.८४ करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू